Literature DB >> 2647469

The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo.

H V Strout1, P P Vicario, R Saperstein, E E Slater.   

Abstract

The in vivo administration of sodium orthovanadate stimulated the incorporation of [14C]glucose into [14C] glycogen, in a dose- and time-dependent manner, in mouse diaphragm. Activation of diaphragm insulin receptor was measured by exogenous tyrosine kinase activity and an antibody that recognizes a conformational change in the receptor beta-subunit upon autophosphorylation. Neither method detected insulin receptor activation by in vivo vanadate administration, suggesting that vanadate's insulin-mimetic effect on mouse diaphragm glycogenesis occurs at a site distal to the insulin receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647469     DOI: 10.1210/endo-124-4-1918

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Oral administration of vanadate to streptozotocin-diabetic rats restores the glucose-induced activation of liver glycogen synthase.

Authors:  M Bollen; M Miralpeix; F Ventura; B Toth; R Bartrons; W Stalmans
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 2.  Alternative therapies for diabetes and its cardiac complications: role of vanadium.

Authors:  Tod A Clark; Justin F Deniset; Clayton E Heyliger; Grant N Pierce
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 3.  Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.

Authors:  A P Bevan; P G Drake; J F Yale; A Shaver; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 4.  Unique and selective mitogenic effects of vanadate on SV40-transformed cells.

Authors:  H Wang; R E Scott
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.

Authors:  M B Anand-Srivastava; J H McNeill; X P Yang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 6.  In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus.

Authors:  A B Goldfine; D C Simonson; F Folli; M E Patti; C R Kahn
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

7.  Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver.

Authors:  S Pugazhenthi; F Tanha; B Dahl; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

8.  Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases.

Authors:  S K Pandey; J L Chiasson; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

9.  Influence of vanadate on glycolysis, intracellular sodium, and pH in perfused rat hearts.

Authors:  C F Geraldes; M M Castro; A D Sherry; R Ramasamy
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

10.  Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.

Authors:  M C Cam; R A Pederson; R W Brownsey; J H McNeill
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.